Allergy researchers at The University of British Columbia (UBC) have found that antibiotic use in early life alters gut bacteria and enhances future susceptibility to inflammatory lung disease. The study, led by AllerGen investigator Dr. Kelly McNagny, a professor in …
A new study by AllerGen researchers has shown that children treated with antibiotics in the first year of life are more than twice as likely to be overweight later in childhood compared to children who were unexposed. The study, published …
New study links antibiotic use to overweight in children Read more »
AllerGen investigator Dr. Kelly McNagny (The University of British Columbia) is co-editor of a new edition of Mast Cells: Methods and Protocols, a volume in the Methods in Molecular Biology series published by Humana Press. The text is intended for …
Network members contribute to new volume on the study of mast cells Read more »
Researchers in AllerGen’s Clinical Investigator Collaborative (CIC) have shown that a new drug (quilizumab) successfully blocks the production of an immune system protein, reducing symptoms of allergic asthma. The study, led by Dr. Gail Gauvreau (McMaster University), was conducted by …
CIC investigators test new drug for allergic asthma Read more »
A new study by AllerGen researchers reveals that low-income families affected by food allergies felt “unsafe” procuring allergen-free foods at food banks and discount supermarkets, may be misinformed the social assistance health insurance plan, and distanced themselves from other low-income …
Low income, high risk: the overlapping stigmas of food allergy and poverty Read more »
Researchers at AllerGen’s Clinical Investigator Collaborative (CIC) have discovered that an antibody can block a specific protein in the lungs and reduce the symptoms of inflammation and bronchoconstriction experienced by people with mild allergic asthma. The study, published in the …
CIC investigators publish new findings for allergic asthma Read more »
The Asthma Society of Canada releases a study of the personal, social, medical and economic burden of Severe Asthma in Canada. Read Severe Asthma: The Canadian Patient Journey Full report / Executive Summary
Biobanks are important research platforms that involve the collection and storage of human health data and biological samples, including DNA, blood, urine and tissues. According to AllerGen Principal Investigator and health law expert, Professor Tim Caulfield, biobanks may operate in murky waters, facing …
AllerGen researchers at The University of British Columbia, University of Alberta and University of Manitoba, in partnership with collaborators in Sweden, Germany, and the Netherlands, have identified that children with a specific genetic profile may be at an increased risk …
Traffic fumes affect asthma in children genetically susceptible to the disease Read more »
AllerGen trainee and Banting Postdoctoral Fellow Meghan Azad (University of Alberta) is lead author on an article that concludes there is insufficient evidence to recommend probiotic supplementation for the prevention of childhood asthma and wheeze. Published in the December 2013 …
Trainee Meghan Azad publishes on probiotics and childhood asthma in BMJ Read more »
Childhood allergic rhinitis, traffic-related air pollution, and variability in the GSTP1, TNF, TLR2, and TLR4 genes: Results from the TAG Study Elaine Fuertes, Michael Brauer, Elaina MacIntyre, Mario Bauer, Tom Bellander, Andrea von Berg, Dietrich Berdel, Bert Brunekreef, Moira Chan-Yeung, …
AllerGen Trainee’s Research Featured in The Journal of Allergy and Clinical Immunology Read more »
Twelve AllerGen researchers are featured in the July issue of The Journal of Allergy and Clinical Immunology (JACI), July 2013 (Volume 132, Issue 1). JACI, an official journal of the American Academy of Allergy, Asthma & Immunology (AAAAI), features the latest, cutting-edge …